Potent and durable gene modulation in heart and muscle with chemically defined lipophilic siRNAs
Nucleic Acids Research · 26.11.2025 · 53 (22)
DOI: 10.1093/nar/gkaf1374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 23.12.2025. Verfasst von Hassan H Fakih und 19 weiteren Autor:innen. Beteiligte Einrichtung: RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States. Hauptthemen laut MEDLINE: RNA, Small Interfering, Myostatin, Myocardium, Muscle, Skeletal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Small interfering RNAs (siRNAs) hold promise for treating cardiac and muscular diseases, but robust and scalable delivery remains a hurdle. While biologic–siRNA conjugates (e.g. antibodies) are in clinical development, their manufacturing is complex. Lipophilic siRNAs are readily chemically synthesized at scale and support effective heart and muscle delivery. Here, we refine siRNA chemical design for enhanced potency and durability to support clinically relevant silencing. Targeting myostatin (MSTN), a key gene in muscle-wasting, a single subcutaneous dose in mice achieved potent silencing (80% inhibition up to 6 weeks, 30% up to 14 weeks). Biweekly dosing led to over 95% MSTN reduction for half-a-year with no observed toxicity. This resulted in muscle growth, increased lean mass, and improved grip strength. Phenotypical benefits extended beyond direct target silencing, suggesting prolonged effects. The siRNA scaffold was effective across multiple muscle groups, with its modularity confirmed by three additional targets. Optimized dosing extended durability to 20 weeks without compromising phenotypic outcomes. As a proof of concept, MSTN inhibition with siRNAs successfully combated muscle wasting in an inflammatory myopathy model (cardiotoxin). These findings pave the way for long-lasting gene modulation in heart and muscle, offering new therapeutic strategies for muscular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
- Department of Genetic and cellular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
ORCID-Profile: Hassan H Fakih, Jillian Caiazzi, Samuel R Hildebrand, Dimas Echeverria, Ken Yamada, Julia F Alterman, Anastasia Khvorova
Förderung
- NIGMS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Fakih, H. H., Lochmann, C., Gagnon, R., Summers, A., Caiazzi, J., Buchwald, J. E., Tang, Q., Maru, B., Hildebrand, S. R., Abideen, M. Z. U. I., Furgal, R. C., Gross, K. Y., Yang, Y. S., Cooper, D., Monopoli, K. R., Echeverria, D., Shim, J. H., Yamada, K., Alterman, J. F., & Khvorova, A. (2025). Potent and durable gene modulation in heart and muscle with chemically defined lipophilic siRNAs. Nucleic Acids Research, 53(22). https://doi.org/10.1093/nar/gkaf1374
Vancouver
Fakih HH, Lochmann C, Gagnon R, Summers A, Caiazzi J, Buchwald JE, et al. Potent and durable gene modulation in heart and muscle with chemically defined lipophilic siRNAs. Nucleic Acids Research. 2025;53(22). doi:10.1093/nar/gkaf1374
BibTeX
@article{Fakih2025,
author = {Fakih, Hassan H and Lochmann, Clemens and Gagnon, Rosemary and Summers, Ashley and Caiazzi, Jillian and Buchwald, Julianna E and Tang, Qi and Maru, Bruktawit and Hildebrand, Samuel R and Abideen, Mohammad Zain U I and Furgal, Raymond C and Gross, Katherine Y and Yang, Yeon-Suk and Cooper, David and Monopoli, Kathryn R and Echeverria, Dimas and Shim, Jae-Hyuck and Yamada, Ken and Alterman, Julia F and Khvorova, Anastasia},
title = {Potent and durable gene modulation in heart and muscle with chemically defined lipophilic siRNAs},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {22},
doi = {10.1093/nar/gkaf1374}
}
EUVIMED